COH Share Price

Open 130.93 Change Price %
High 131.10 1 Day -0.61 -0.47
Low 130.05 1 Week -1.88 -1.42
Close 130.20 1 Month 1.54 1.20
Volume 169596 1 Year 26.29 25.30
52 Week High 144.12
52 Week Low 98.47
COH Important Levels
Resistance 2 131.17
Resistance 1 130.77
Pivot 130.45
Support 1 129.63
Support 2 129.23
ASX Australia Most Active Stocks
AGO 0.04 0.00%
AGO 0.04 0.00%
AGO 0.04 0.00%
GPP 0.04 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
SDL 0.01 0.00%
SDL 0.01 0.00%
SDL 0.01 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
SER 0.02 100.00%
SER 0.02 100.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
PMQ 0.03 50.00%
ARV 0.12 33.33%
PRR 0.04 33.33%
PRR 0.04 33.33%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
RMI 0.01 -50.00%
RMI 0.01 -50.00%
IMU 0.01 -50.00%
IMU 0.01 -50.00%
GDY 0.01 -50.00%
More..

Cochlear Ltd (ASX: COH)

COH Technical Analysis 3
As on 24th Feb 2017 COH Share Price closed @ 130.20 and we RECOMMEND Buy for LONG-TERM with Stoploss of 124.58 & Buy for SHORT-TERM with Stoploss of 124.92 we also expect STOCK to react on Following IMPORTANT LEVELS.
COH Target for February
1st Target up-side 129.26
2nd Target up-side 132.12
3rd Target up-side 134.99
1st Target down-side 121.08
2nd Target down-side 118.22
3rd Target down-side 115.35
COH Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.cochlear.com
COH Address
COH
1 University Avenue
Macquarie University, NSW 2109
Australia
Phone: 61 2 9428 6555
Fax: 61 2 9428 6352
COH Latest News
Interactive Technical Analysis Chart Cochlear Ltd ( COH ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Cochlear Ltd
COH Business Profile
Cochlear Limited provides implantable hearing solutions. It offers the Cochlear Nucleus range of cochlear implant systems; Baha bone conduction implants for treating conductive hearing loss, mixed hearing loss, and single-sided deafness; bone anchored prosthetics, such as the Cochlear Vistafix bone-anchored facial prosthetic solution to enhance the attachment and cosmetic outcome of facial prostheses; and support services. The company provides its products directly, as well as through distributors and agents in the United States, Canada, and Latin America; Europe, the Middle East, and Africa; and Australasia and Asia. Cochlear Limited is headquartered in Macquarie University, Australia.